Anna Alari is a PhD student in Epidemiology of the University of Paris Saclay, under the direction of Laurence Watier (INSERM). The aim of her research is to evaluate the impact of public health policies on invasive pneumococcal diseases (IPD).
MIBAC: Antibiotic use in the community
Since 2002 a centralized storage of therapeutic or preventive medications of bacterial infections in the community (MIBAC) has been initiated. Reimbursements for all systemic antibiotics (class J01 of the Anatomical Therapeutic classification), as well […]
Antiinfectives drugs and invasive pneumococcal diseases
In addition to a direct effect on the individual, the consumption of antiinfective drugs may have an indirect ecological benefit only visible at the population level. Moreover indirect ecological adverse effects may also exist […]